Is Actinium Pharmaceuticals, Inc. (ATNM) a Buy, Sell, or Hold?
AMEX : ATNM
Actinium Pharmaceuticals, Inc. — Analyst Ratings
$0.8 USD
$0.01 (1.65%)
- Volume
- 47.04K
- Average Volume
- 114.56K
- Market Capitalization
- $25.1M
- P/E Ratio
- -1.07
- Dividend Yield
- 0.00%
- Price Target
- $4.95
- Year High
- $1.81
- Year Low
- $0.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.89
Analyst Consensus Summary
Consensus Rating
Sell
11 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-83.8%
vs Current Price
Price Target
$4.95
Average TargetPrice Target Range
Lowest Target
$4.00
-80.0% DOWNSIDE
Average Target
$4.95
Median Estimate
Highest Target
$24.26
-96.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 11 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Maxim Group | Jason McCarthy | $5 | $2.46 | 2024-08-06 04:10 AM | 103.3% |
| H.C. Wainwright | Joseph Pantginis | $4 | $2.66 | 2024-08-06 02:37 AM | 50.4% |
| Stephens | Sudan Loganathan | $25 | $8.59 | 2024-05-13 12:22 PM | 191.0% |